BioCentury
ARTICLE | Company News

Talecris sales and marketing update

November 8, 2010 8:00 AM UTC

Talecris launched Prolastin-C in Canada to treat panacinar emphysema in patients with alpha1-antitrypsin ( AAT) deficiency. The company said Prolastin-C, which is a more purified and concentrated for...